Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the absorption,metabolism and excretion of CBP-307 in healthy chinese male subjects.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05040113
Study type Interventional
Source Suzhou Connect Biopharmaceuticals, Ltd.
Contact Tian Zhang
Phone (+86)0512-53577866
Email [email protected]
Status Recruiting
Phase Phase 1
Start date September 4, 2021
Completion date January 2022

See also
  Status Clinical Trial Phase
Completed NCT03267732 - A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Phase 1
Completed NCT01433835 - Safety and Pharmacokinetics of Single Oral Doses of MBX-400 in Healthy Volunteers Phase 1
Completed NCT04029090 - A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects Phase 1
Recruiting NCT04586985 - Safety, Tolerability and Pharmacokinetics of FTX-6058 Phase 1
Completed NCT04481789 - Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) Phase 1
Recruiting NCT04629131 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults Phase 1
Completed NCT04203862 - A Study of NPC-22 in Healthy Adult Males Phase 1
Completed NCT04521192 - Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects Phase 1
Not yet recruiting NCT04400123 - A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers Phase 1
Recruiting NCT04811469 - Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults Phase 1
Completed NCT04291846 - A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects Phase 1
Not yet recruiting NCT04395053 - A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers Phase 1
Completed NCT01364441 - Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects Phase 1
Completed NCT02691702 - Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers Phase 1
Completed NCT04493281 - Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects Phase 1
Completed NCT01376063 - Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects Phase 1
Completed NCT04481750 - Study of Oral Edaravone in Healthy Adult Males Phase 1
Completed NCT03794180 - Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects Phase 1
Completed NCT02168595 - Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers Phase 1
Terminated NCT01379586 - A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers Phase 1